Vincerx Pharma, Inc.

NasdaqCM:VINC Stock Report

Market Cap: US$2.7m

Vincerx Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VINC?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds110,3256.58%
Individual Insiders190,21711.3%
Institutions301,52718%
General Public1,075,72664.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.9%.

Top Shareholders

Top 25 shareholders own 35.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.58%
Prosight Management, LP
110,325US$174.3k-11.3%0.04%
5.11%
Ahmed Hamdy
85,713US$135.4k0%no data
4.82%
John Byrd
80,910US$127.8k0%no data
4.82%
Sage Rhino Capital, LLC
80,910US$127.8k-5%0.03%
2.66%
Rock Springs Capital Management LP
44,585US$70.4k0%no data
2.01%
Point72 Asset Management, L.P.
33,709US$53.3k0%no data
1.88%
Goldman Sachs Group, Investment Banking and Securities Investments
31,571US$49.9k0%no data
1.87%
The Vanguard Group, Inc.
31,372US$49.6k0%no data
1.62%
ExodusPoint Capital Management, LP
27,101US$42.8k13.4%no data
1.05%
Marshall Wace LLP
17,678US$27.9k7.62%no data
0.75%
Geode Capital Management, LLC
12,540US$19.8k8.67%no data
0.69%
Tom Thomas
11,497US$18.2k0%no data
0.35%
Rubric Capital Management LP
5,843US$9.2k0%no data
0.26%
Raquel Izumi
4,311US$6.8k0%no data
0.2%
Renaissance Technologies LLC
3,300US$5.2k-49.3%no data
0.17%
State Street Global Advisors, Inc.
2,850US$4.5k0%no data
0.16%
Brian Druker
2,740US$4.3k0%no data
0.14%
BlackRock, Inc.
2,354US$3.7k0%no data
0.13%
Kevin Haas
2,139US$3.4k0%no data
0.11%
Alexander Seelenberger
1,907US$3.0k15.1%no data
0.1%
Northern Trust Global Investments
1,714US$2.7k0%no data
0.095%
Susquehanna International Group, LLP, Asset Management Arm
1,599US$2.5k0%no data
0.062%
Jane Street Group, LLC, Asset Management Arm
1,045US$1.7k0%no data
0.057%
Laura Bushnell
960US$1.5k0%no data
0.055%
XTX Holdings Limited, Asset Management Arm
916US$1.4k0.77%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/03 17:40
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vincerx Pharma, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
I-Eh JenLaidlaw & Company (UK) Ltd
Wei ChangLeerink Partners LLC